- Investing Ideas
- Indian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Indian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
3
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
Strides Pharma Science
Market Cap: ₹97.7b
A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.
STAR
₹1,072.80
7D
4.0%
1Y
22.7%
Senores Pharmaceuticals
Market Cap: ₹60.7b
Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.
SENORES
₹1,292.40
7D
-7.4%
1Y
87.6%
Viyash Scientific
Market Cap: ₹112.1b
Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.
512529
₹251.90
7D
-0.5%
1Y
46.3%